Ahmed Hamdy M.D., See Remarks at Vincerx Pharma, Inc. (VINC), bought 22,300 shares at $0.96 ($21K) on 2023-08-10, disclosed to the SEC on 2023-08-10.
Open-market purchase of $21k VINC by See Remarks. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.95 | 16,900 | $16K | 75.6% |
| 2 | $0.96 | 5,400 | $5K | 24.4% |
| Total | $0.95 avg | 22,300 | $21K | 100% |
| Filing → |
| VINC | BUY | 2021-12-27 | $65K | — | Filing → |
| VINC | BUY | 2021-06-30 | $200K | — | Filing → |
| PCYC | SELL | 2010-10-07 | $123K | — | Filing → |